PUNCH CD3-OLS: a phase 3 prospective observational cohort study to evaluate the safety and efficacy of fecal microbiota, live-jslm (REBYOTA) in adults with recurrent Clostridioides difficile infection

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Clinical Infectious Diseases

Topics

Biology

Bioinformatics

Medicine

Epidemiology

Microbiology

Show all topics

DOI

10.1093/cid/ciae437

License

CC-BY

Other Formats

PDF